ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,551.91
(
0.03%
)
US Tech 100
15,572.80
(
0.04%
)
Dow Jones
35,415.89
(
0.23%
)
Brent Oil
81.435
(
1.74%
)
Bitcoin
38,258.24
(
2.69%
)
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NeuroOne Medical Technologies Corporation (NMTC)

  7. NeuroOne Medical Technologies Corporation (NMTC) News

NMTC NeuroOne Medical Technologies Corporation

1.35
0.015 (1.12%)
Last Updated: 15:24:07
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
NeuroOne Medical Technologies Corporation NMTC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.015 1.12% 1.35 15:24:07
Open Price Low Price High Price Close Price Prev Close
1.34 1.33 1.3788 1.335
more quote information »

Recent News

Date Time Source Heading
11/16/202308:00EDGAR2Form 8-K - Current report
11/16/202308:00GLOBENeuroOne® Announces Patent Allowance for Drug Delivery..
11/14/202317:15GLOBENeuroOne® Appoints Medtech Executive Christopher R. Volker..
11/13/202318:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202317:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202317:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202308:15EDGAR2Form 8-K - Current report
11/07/202308:00GLOBENeuroOne® Provides Progress Update on FDA 510(k) Submission..
11/03/202316:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202315:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202315:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/13/202309:30GLOBENeuroOne® to Present at the ThinkEquity Conference on..
10/03/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202311:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/06/202316:00GLOBENeuroOne® to Present at the H.C. Wainwright 25th Annual..
9/05/202311:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202311:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202311:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202316:15EDGAR2Form 8-K - Current report
8/14/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202316:00GLOBENeuroOne® Reports Third Quarter Fiscal Year 2023 Financial..
8/08/202316:00GLOBENeuroOne® to Report Third Quarter Fiscal Year 2023 Financial..
8/01/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/01/202315:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/01/202315:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/27/202316:02EDGAR2Form 8-K - Current report
7/26/202316:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
7/25/202308:00GLOBENeuroOne Medical Technologies Corporation Announces Pricing..
7/24/202316:43EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
7/24/202316:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
7/24/202316:03GLOBENeuroOne Medical Technologies Corporation Announces Proposed..
7/05/202314:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/05/202313:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/05/202313:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/12/202308:35GLOBENeuroOne® Submits 510(k) Application to FDA for OneRF™..
5/11/202316:00GLOBENeuroOne® Reports Second Quarter Fiscal Year 2023 Financial..
5/11/202312:17GLOBENeuroOne® to Report Second Quarter Fiscal Year 2023..
5/10/202309:00GLOBENeuroOne® Announces First Clinical Case Using Evo® sEEG..
5/05/202315:08GLOBENeuroOne Reports Inducement Grant Under Nasdaq Listing Rule..
5/05/202309:00GLOBENeuroOne® to Present at the Sidoti Micro-Cap Virtual..
5/02/202309:00GLOBENeuroOne® Announces U.S. Commercial Launch of Evo® sEEG..
4/27/202316:00GLOBENeuroOne Reports Inducement Grant Under Nasdaq Listing Rule..
3/16/202307:30PRNUSNeuroOne® Successfully Completes Initial Animal Implant of..
3/09/202309:00PRNUSNeuroOne®#¹⁶⁰;to Participate in the 35th Annual Roth..
3/07/202307:30PRNUSNeuroOne® Awarded U.S. Patent Covering Novel and Proprietary..

Your Recent History

NASDAQ
NMTC
NeuroOne Medical Technol...

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com